Cited by 4,360SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmune responses and vaccinations

The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.

The trinity of COVID-19: immunity, inflammation and intervention

Open access

Tay, Matthew Zirui, Poh, Chek Meng, Rénia, Laurent, MacAry, Paul A., Ng, Lisa F. P.·2020·Nature Reviews Immunology

DOI 10.1038/s41577-020-0311-8PMC PMC7187672

Open this paper in CoChat — free account Open PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of SARS-CoV-2, understanding the fundamental physiological and immunological processes underlying the clinical manifestations of COVID-19 is vital for the identification and rational design of effective therapies. Here, we provide an overview of the pathophysiology of SARS-CoV-2 infection. We describe the interaction of SARS-CoV-2 with the immune system and the subsequent contribution of dysfunctional immune responses to disease progression. From nascent reports describing SARS-CoV-2, we make inferences on the basis of the parallel pathophysiological and immunological features of the other human coronaviruses targeting the lower respiratory tract - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Finally, we highlight the implications of these approaches for potential therapeutic interventions that target viral infection and/or immunoregulation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41577-020-0311-8

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Gautret, P., Lagier, J., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Esteves-Vieira, V., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
Retracted
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575

Show all 136 references

Research works printed but not linked: 3

Pipeline Review. APEIRON’s respiratory drug product to start pilot clinical trial to treat coronavirus disease COVID-19 in China. Pipeline Review https://pipelinereview.com/index.php/2020022673884/Proteins-and-Peptides/APEIRONs-respiratory-drug-product-to-start-pilot-clinical-trial-to-treat-coronavirus-disease-COVID-19-in-China.html (2020).
Humanigen. Humanigen partners with CTI, a leading contract research organization, for planned phase III study for lenzilumab for coronavirus treatment. Humanigen https://www.humanigen.com/press/Humanigen-Partners-With-CTI%2C-A-Leading-Contract-Research-Organization%2C-For-Planned-Phase-III-Study-For-Lenzilumab-For-Coronavirus-Treatment (2020).
VIR. Press release details: Vir Biotechnology applying multiple platforms to address public health risk from Wuhan coronavirus. VIR https://investors.vir.bio/news-releases/news-release-details/vir-biotechnology-applying-multiple-platforms-address-public (2020).

Sorted by citations

Items 601–700 of 1,002

A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor
Souza, P. F. N., Lopes, F. E. S., Amaral, J. L., Freitas, C. D. T., & Oliveira, J. T. A. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.174 · Cited by 60
Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID‐19
Heister, P. M., & Poston, R. N. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.653 · Cited by 60
Plant-based vaccines and antibodies to combat COVID-19: current status and prospects
Dhama, K., Natesan, S., Yatoo, M. I., Patel, S. K., Tiwari, R., Saxena, S. K., & Harapan, H. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1842034 · Cited by 60
Insights on cross-species transmission of SARS-CoV-2 from structural modeling
Rodrigues, J., Barrera-Vilarmau, S., Teixeira, J. M. C., Sorokina, M., Seckel, E., Kastritis, P. L., & Levitt, M. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008449 · Cited by 60
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Bachmann, M. F., Mohsen, M. O., Zha, L., Vogel, M., & Speiser, D. E. (2021) · npj Vaccines · doi:10.1038/s41541-020-00264-6 · Cited by 59
A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro
Cheng, M. H., Porritt, R. A., Rivas, M. N., Krieger, J., Ozdemir, A. B., Garcia, G., Arumugaswami, V., Fries, B. C., Arditi, M., & Bahar, İ. (2021) · Structure · doi:10.1016/j.str.2021.04.005 · Cited by 59
Autoimmunity and COVID-19 – The microbiotal connection
Katz-Agranov, N. S., & Zandman‐Goddard, G. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102865 · Cited by 64
SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism
Jing, Y., Luo, L., Chen, Y., Westerberg, L. S., Zhou, P., Xu, Z. P., Herrada, A. A., Park, C.-S., Kubo, M., Mei, H., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00749-3 · Cited by 61
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial
Mazeraud, A., Jamme, M., Mancusi, R. L., Latroche, C., Mégarbane, B., Siami, S., Zarka, J., Moneger, G., Santoli, F., Argaud, L., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00440-9 · Cited by 64
Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance
Yadav, S., Priya, A., Borade, D. R., & Agrawal-Rajput, R. (2022) · Immunologic Research · doi:10.1007/s12026-022-09330-8 · Cited by 64
Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series
de Guadiana‐Romualdo, L. G., Mulero, M. D. R., Olivo, M. H., Rojas, C. R., Ramos-Arenas, V., Morales, M. G., Blázquez-Abellán, A., Conesa‐Zamora, P., García-García, J., Hernández, A. C., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.08.010 · Cited by 60
Clinical course and prognostic factors of COVID-19 infection in an elderly hospitalized population
Mostaza, J. M., García-Iglesias, F., González-Alegre, T., Blanco, F., Varas, M., Hernández-Blanco, C., Hontañón, V., Jaras, M. J., Martínez‐Prieto, M., Menéndez-Saldaña, A., et al. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104204 · Cited by 59
Peptides to combat viral infectious diseases
Al-Azzam, S., Ding, Y., Liu, J., Pandya, P., Ting, J. P., & Afshar, S. (2020) · Peptides · doi:10.1016/j.peptides.2020.170402 · Cited by 57
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study
Monreal, E., de la Maza, S. S., Natera‐Villalba, E., Beltrán‐Corbellini, Á., Rodríguez‐Jorge, F., Fernández-Velasco, J. I., Walo-Delgado, P. E., Muriel, A., Zamora, J., Cánovas, A. A., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04078-1 · Cited by 60
Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
Masre, S. F., Jufri, N. F., Ibrahim, F. W., & Raub, S. H. A. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2207 · Cited by 62
Metabolic Alterations in SARS-CoV-2 Infection and Its Implication in Kidney Dysfunction
Andrade-Silva, M., da Silva, A. R. P. A., do Amaral, M. A., de Fragas, M. G., & Câmara, N. O. S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.624698 · Cited by 60
Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
Hasan, A., Al‐Ozairi, E., Albaqsumi, Z., Ahmad, R., & Al‐Mulla, F. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s280706 · Cited by 56
Role of red blood cell distribution width, as a prognostic indicator in COVID‐19: A systematic review and meta‐analysis
Sarkar, S., Kannan, S., Khanna, P., & Singh, A. K. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2264 · Cited by 59
COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management
Yasmin, F., Najeeb, H., Naeem, A., Dapke, K., Phadke, R., Asghar, M. S., Shah, S. M. I., Berardis, D. D., & Ullah, I. (2021) · Diseases · doi:10.3390/diseases9040065 · Cited by 59
Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy
Jin, S., He, X., Ma, L., Zhuang, Z., Wang, Y., Lin, M., Cai, S., Wei, L., Wang, Z., Zhao, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32957-y · Cited by 59
Understanding COVID-19 in children: immune determinants and post-infection conditions
Rotulo, G. A., & Palma, P. (2023) · Pediatric Research · doi:10.1038/s41390-023-02549-7 · Cited by 60
Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus–Host Interaction and Pathogenesis
Zhang, H., Huanying, Z., Zhu, J., Dong, Q., Wang, J., Fan, H., Chen, Y., Zhang, X., Han, X., Li, Q., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00758 · Cited by 60
Tocilizumab and COVID-19: Timing of Administration and Efficacy
Abidi, E., Nekidy, W. S. E., Alefishat, E. A., Rahman, N., Petroianu, G. A., El-Lababidi, R. M., & Mallat, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.825749 · Cited by 61
Peripheral Blood Examination Findings in SARS-CoV-2 Infection
Nazarullah, A. N., Liang, C., Villarreal, A., Higgins, R. A., & Mais, D. D. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa108 · Cited by 59
Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky, V. N., Elrashdy, F., Aljaddawi, A. A., Ali, S. M., Khan, R. H., & Redwan, E. M. M. M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24752 · Cited by 59
Pediatric COVID-19 and Appendicitis: A Gut Reaction to SARS-CoV-2?
Malhotra, A., Sturgill, M. G., Whitley-Williams, P. N., Lee, Y.-H., Esochaghi, C., Rajasekhar, H., Olson, B., & Gaur, S. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002998 · Cited by 58
Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury
Li, X., Berg, N. K., Mills, T., Zhang, K., Eltzschig, H. K., & Yuan, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604944 · Cited by 59
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
Pelaia, C., Calabrese, C., Garofalo, E., Bruni, A., Vatrella, A., & Pelaia, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063059 · Cited by 62
Mechanisms of immunothrombosis in COVID-19
Portier, I., Campbell, R. A., & Denorme, F. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000666 · Cited by 58
SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer’s Disease Patients
Chiricosta, L., Gugliandolo, A., & Mazzon, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413603 · Cited by 59
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
Teixeira, L., Temerozo, J. R., Pereira-Dutra, F. S., Ferreira, A. C., Mattos, M., Gonçalves, B. S., Sacramento, C. Q., Palhinha, L., Cunha‐Fernandes, T., Dias, S. D. S. G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.820131 · Cited by 55
Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells
Puhm, F., Allaeys, I., Lacasse, É., Dubuc, I., Galipeau, Y., Zaid, Y., Khalki, L., Belleannée, C., Durocher, Y., Brisson, A. R., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007444 · Cited by 58
Immune responses in mildly versus critically ill COVID-19 patients
Nasrollahi, H., Talepoor, A. G., Saleh, Z., Vakili, M. E., Heydarinezhad, P., Karami, N., Noroozi, M., Meri, S., & Kalantar, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1077236 · Cited by 63
Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review
Sessa, F., Bertozzi, G., Cipolloni, L., Baldari, B., Cantatore, S., D’Errico, S., Mizio, G. D., Asmundo, A., Castorina, S., Salerno, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072026 · Cited by 59
Regulation of Host Immune Responses against Influenza A Virus Infection by Mitogen-Activated Protein Kinases (MAPKs)
Yu, J., Sun, X., Goie, J. Y. G., & Zhang, Y. (2020) · Microorganisms · doi:10.3390/microorganisms8071067 · Cited by 59
Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19
Saul, S., & Einav, S. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00343 · Cited by 56
Characteristics and Outcomes of In-Hospital Cardiac Arrest Events During the COVID-19 Pandemic
Miles, J. A., Saldarriaga, M. M., Rios, S. A., Sokol, S. I., Langston, M., Hahn, S. R., Leiderman, E., Salgunan, R., Soghier, I., Gulani, P., et al. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.007303 · Cited by 57
COVID‐19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?
Saeedi‐Boroujeni, A., Mahmoudian‐Sani, M., Bahadoram, M., & Alghasi, A. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13503 · Cited by 57
COVID-19 grave: entenda o papel da imunidade, do endotélio e da coagulação na prática clínica
Brandão, S. C. S., Godoi, E. T. A. M., Ramos, J. D. O. X., de Melo, L. M. M. P., & SARINHO, E. S. C. (2020) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.200131 · Cited by 67
Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes
Sadhukhan, P., Ugurlu, M. T., & Hoque, M. O. (2020) · Cancers · doi:10.3390/cancers12123822 · Cited by 57
Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS
Haeberle, H. A., Magunia, H., Lang, P., Gloeckner, H., Körner, A., Koeppen, M., Backchoul, T., Malek, N. P., Handgretinger, R., Rosenberger, P., et al. (2021) · Journal of Intensive Care Medicine · doi:10.1177/0885066621997365 · Cited by 56
ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients
Ramos, S. G., Rattis, B. A. D. C., Giulia Ottaviani, M., Celes, M. R. N., & Dias, E. P. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.04.010 · Cited by 59
Clinical laboratory evaluation of COVID-19
Chen, Z., Xu, W., Ma, W., Shi, X., Li, S., Hao, M., Fang, Y., & Zhang, L. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.04.022 · Cited by 57
“These cytokines include IL-1β, IL-7, IL-10, G-CSF, IFN-γ, IP10, MCP1, MIP-1α, TNF-α and VEGF.”
Influential
Prognostic Significance of Urinary Biomarkers in Patients Hospitalized With COVID-19
Menez, S. P., Moledina, D. G., Thiessen‐Philbrook, H., Wilson, F. P., Obeid, W., Simonov, M., Yamamoto, Y., Corona‐Villalobos, C. P., Chang, C. T., Garibaldi, B. T., et al. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.09.008 · Cited by 57
Impact of Dietary Fiber on Inflammation and Insulin Resistance in Older Patients: A Narrative Review
Niero, M., Bartoli, G., Colle, P. D., Scarcella, M., & Zanetti, M. (2023) · Nutrients · doi:10.3390/nu15102365 · Cited by 61
Single-step, wash-free digital immunoassay for rapid quantitative analysis of serological antibody against SARS-CoV-2 by photonic resonator absorption microscopy
Zhao, B., Che, C., Wang, W., Li, N., & Cunningham, B. T. (2020) · Talanta · doi:10.1016/j.talanta.2020.122004 · Cited by 54
Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection
Campana, P., Parisi, V., Leosco, D., Bencivenga, D., Ragione, F. D., & Borriello, A. (2020) · Cells · doi:10.3390/cells9092046 · Cited by 55
The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia
Holder, K., & Reddy, P. H. (2020) · The Neuroscientist · doi:10.1177/1073858420960443 · Cited by 55
Serpiginous choroiditis presenting after SARS-CoV-2 infection: A new immunological trigger?
Providência, J., Fonseca, C., Henriques, F., & Proença, R. D. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672120977817 · Cited by 56
Electrochemical sensing: A prognostic tool in the fight against COVID-19
Kotru, S., Klimuntowski, M., Ridha, H., Uddin, Z., Askhar, A. A., Singh, G., & Howlader, M. M. R. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2021.116198 · Cited by 57
Sex Hormones and Lung Inflammation
Reyes-García, J., Montaño, L. M., Carbajal-García, A., & Wang, Y.-X. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-68748-9_15 · Cited by 60
Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
Ricci, D., Etna, M. P., Rizzo, F., Sandini, S., Severa, M., & Coccia, E. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137017 · Cited by 61
Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes
Liu, N., Jiang, C., Cai, P., Shen, Z., Sun, W., Xu, H. Y., Fang, M., Yao, X., Zhu, L., Gao, X., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109793 · Cited by 55
A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses
Nassar, A. M., Ibrahim, I. M., Amin, F. G., Magdy, M., Elgharib, A. M., Azzam, E. B., Nasser, F., Yousry, K., Shamkh, I. M., Mahdy, S. M., et al. (2021) · Molecules · doi:10.3390/molecules26216455 · Cited by 59
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Rénia, L., Goh, Y. S., Rouers, A., Bert, N. L., Chia, W. N., Chavatte, J., Fong, S., Chang, Z. W., Zhuo, N. Z., Tay, M. Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32312-1 · Cited by 62
Self-citation
Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19
Lev, S., Gottesman, T., Levin, G. S., Lederfein, D., Berkov, E., Diker, D., Zaidman, A., Nutman, A., Ber, T. I., Angel, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245296 · Cited by 56
Expression and characterization of SARS-CoV-2 spike proteins
Schaub, J. M., Chou, C., Kuo, H., Javanmardi, K., Hsieh, C., Goldsmith, J. A., DiVenere, A. M., Le, K. C., Wrapp, D., Byrne, P. O., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00623-0 · Cited by 57
COVID-19 in rheumatic disease patients on immunosuppressive agents
Sharmeen, S., Elghawy, A. A., Zarlasht, F., & Yao, Q. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.05.010 · Cited by 55
Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review
Noorimotlagh, Z., Karami, C., Mirzaee, S. A., Kaffashian, M. R., Mami, S., & Azizi, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106738 · Cited by 55
Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease
Tejera, E., Munteanu, C. R., López‐Cortés, A., Cabrera‐Andrade, A., & Pérez‐Castillo, Y. (2020) · Molecules · doi:10.3390/molecules25215172 · Cited by 59
Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung
Wang, L., Rao, Y., Liu, X., Sun, L., Gong, J., Zhang, H., Shen, L., Bao, A., & Yang, H. Y. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00803-w · Cited by 56
A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19
Zhang, X., Gao, R., Zhou, Z., Tang, X., Lin, J., Wang, L., Zhou, X. H., & Shen, T. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.53685 · Cited by 55
Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients
Okada, Y., Yoshimura, K., Toya, S., & Tsuchimochi, M. (2021) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2021.07.001 · Cited by 56
A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
Logette, E., Lorin, C., Favreau, C., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M., Delattre, É., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.695139 · Cited by 58
A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2
Mohsen, M. O., Baļķe, I., Zinkhan, S., Zeltina, V., Liu, X., Chang, X., Krenger, P. S., Plattner, K., Gharailoo, Z., Vogt, A. S., et al. (2021) · Allergy · doi:10.1111/all.15080 · Cited by 54
SARS-CoV-2 triggers DNA damage response in Vero E6 cells
Victor, J., Deutsch, J., Whitaker, A., Lamkin, E. N., March, A., Zhou, P., Botten, J., & Chatterjee, N. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.09.024 · Cited by 55
SARS-CoV-2 exploits host DGAT and ADRP for efficient replication
Yuan, S., Yan, B., Cao, J., Ye, Z., Liang, R., Tang, K., Luo, C., Cai, J., Chu, H., Chung, T. W.-H., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00338-2 · Cited by 55
Muscle dysfunction in the long coronavirus disease 2019 syndrome: Pathogenesis and clinical approach
Silva, C. C., Bichara, C. N. C., Carneiro, F. R. O., Palácios, V. R. D. C. M., van den Berg, A. V. S., Quaresma, J. A. S., & Falcão, L. F. M. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2355 · Cited by 56
The role of Interleukin-4 in COVID-19 associated male infertility – A hypothesis
Renu, K., Subramaniam, M. D., Chakraborty, R., Myakala, H., Iyer, M., Bharathi, G., Siva, K., Vellingiri, B., & Gopalakrishnan, A. V. (2020) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2020.103213 · Cited by 55
Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial
Milne, S. B., Li, X., Yang, C. X., Cordero, A. I. H., Filho, F. S. L., Yang, C. W. T., Shaipanich, T., van Eeden, S. F., Leung, J. M., Lam, S. C., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00130-2021 · Cited by 55
Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic
Chakhtoura, M., Napoli, N., & Fuleihan, G. E. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154276 · Cited by 55
Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease
Hoque, M. N., Chaudhury, A., Akanda, M. A. M., Hossain, M. A., & Islam, T. (2020) · PeerJ · doi:10.7717/peerj.9689 · Cited by 53
Anakinra in COVID-19: important considerations for clinical trials
King, A. T., Vail, A., O’Leary, C., Hannan, C. J., Brough, D., Patel, H. C., Galea, J. P., Ogungbenro, K., Wright, M. K., Pathmanaban, O. N., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30160-0 · Cited by 54
Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains
Lee, C. H.-J., Pinho, M. P., Buckley, P. R., Woodhouse, I. B., Ogg, G. S., Simmons, A., Napolitani, G., & Koohy, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579480 · Cited by 55
Seroconversion stages COVID19 into distinct pathophysiological states
Galbraith, M. D., Kinning, K. T., Sullivan, K. D., Baxter, R. M., Araya, P., Jordan, K. R., Russell, S., Smith, K. P., Granrath, R. E., Shaw, J. R., et al. (2021) · eLife · doi:10.7554/elife.65508 · Cited by 50
Aging and Options to Halt Declining Immunity to Virus Infections
Palacios-Pedrero, M. Á., Osterhaus, A. D. M. E., Becker, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.681449 · Cited by 55
COVID-19-associated diarrhea
Megyeri, K., Dernovics, Á., Al-Luhaibi, Z. I. I., & Rosztoczy, A. I. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i23.3208 · Cited by 57
Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals
Mahajan, S., Kode, V., Bhojak, K., Coral, K., Lee, K. M., Manoharan, M., Ramesh, A., Sudheendra, H., Srivastava, A., Sathian, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92521-4 · Cited by 54
Asthma and COVID-19: a dangerous liaison?
Lombardi, C., Gani, F., Berti, A., Comberiati, P., Peroni, D. G., & Cottini, M. (2021) · Asthma Research and Practice · doi:10.1186/s40733-021-00075-z · Cited by 56
Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide Consortium to Investigate Host Genetics of COVID-19
Namkoong, H., Edahiro, R., Fukunaga, K., Shirai, Y., Sonehara, K., Tanaka, H., Lee, H., Hasegawa, T., Masahiro, K., Naito, T., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.09.070 · Cited by 56
Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda
Achan, J., Serwanga, A., Wanzira, H., Kyagulanyi, T., Nuwa, A., Magumba, G., Kusasira, S., Sewanyana, I., Tetteh, K., Drakeley, C., et al. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00240-8 · Cited by 53
Cyanobacteria and Algae-Derived Bioactive Metabolites as Antiviral Agents: Evidence, Mode of Action, and Scope for Further Expansion; A Comprehensive Review in Light of the SARS-CoV-2 Outbreak
Pradhan, B., Nayak, R., Patra, S., Bhuyan, P. P., Dash, S. R., Ki, J., Adhikary, S. P., Ragusa, A., & Jena, M. (2022) · Antioxidants · doi:10.3390/antiox11020354 · Cited by 54
The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection
dos Santos, P. K., Sigoli, E., Bragança, L. J. G., & Cornachione, A. S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.813924 · Cited by 57
The Microbiota/Host Immune System Interaction in the Nose to Protect from COVID-19
Stadio, A. D., Costantini, C., Renga, G., Pariano, M., Ricci, G., & Romani, L. R. (2020) · Life · doi:10.3390/life10120345 · Cited by 55
Ultraefficiently Calming Cytokine Storm Using Ti3C2Tx MXene
Wang, T., Sun, X., Guo, X. Y., Zhang, J., Yang, J. H., Tao, S., Guan, J., Zhou, L., Han, J., Wang, C., et al. (2021) · Small Methods · doi:10.1002/smtd.202001108 · Cited by 54
Immunomodulatory and anti-cytokine therapeutic potential of curcumin and its derivatives for treating COVID-19 – a computational modeling
Noor, H., Ikram, A., Rathinavel, T., Kumarasamy, S., Iqbal, M. N., & Bashir, Z. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1873190 · Cited by 54
Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2
Rajasekharan, S., Bonotto, R. M., Alves, L. N., Kazungu, Y., Poggianella, M., Martínez-Orellana, P., Skoko, N., Polez, S., & Marcello, A. (2021) · Viruses · doi:10.3390/v13050808 · Cited by 54
Pathogenesis‐directed therapy of 2019 novel coronavirus disease
Stratton, C. W., Tang, Y., & Lu, H. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26610 · Cited by 59
Hyperinflammation and Immune Response Generation in COVID-19
Mishra, K. P., Singh, A. K., & Singh, S. B. (2020) · NeuroImmunoModulation · doi:10.1159/000513198 · Cited by 53
COVID-19-associated liver injury: from bedside to bench
Li, D., Ding, X., Xie, M., Tian, D., & Xia, L. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01760-9 · Cited by 54
Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019
Meeran, M. F. N., Javed, H., Sharma, C., Goyal, S. N., Kumar, S., Jha, N. K., & Ojha, S. K. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e05990 · Cited by 57
Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted
Borah, P., Deb, P. K., Chandrasekaran, B., Goyal, M., Bansal, M., Hussain, S., Shinu, P., Venugopala, K. N., Al‐Shar’i, N. A., Deka, S., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.627723 · Cited by 53
CD38 in the age of COVID-19: a medical perspective
Horenstein, A. L., Faini, A. C., & Malavasi, F. (2021) · Physiological Reviews · doi:10.1152/physrev.00046.2020 · Cited by 53
Corticosteroids for COVID-19: worth it or not?
Akter, F., Araf, Y., & Hosen, M. J. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06793-0 · Cited by 53
First structure–activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery
Amin, S. A., Banerjee, S., Singh, S., Qureshi, I. A., Gayen, S., & Jha, T. (2021) · Molecular Diversity · doi:10.1007/s11030-020-10166-3 · Cited by 56
STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamstersPreprint
Boudewijns, R., Thibaut, H. J., Kaptein, S. J. F., Li, R., Vergote, V., Seldeslachts, L., Keyzer, C. D., Bervoets, L., Sharma, S., Weyenbergh, J. V., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.23.056838 · Cited by 53
A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19
Claverie, J. (2020) · Viruses · doi:10.3390/v12060646 · Cited by 53
Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak?
Caruso, P., Longo, M., Esposito, K., & Maiorino, M. I. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108219 · Cited by 52
Insight into the pediatric and adult dichotomy of COVID‐19: Age‐related differences in the immune response to SARS‐CoV‐2 infection
Fialkowski, A., Gernez, Y., Arya, P., Weinacht, K. G., Kinane, T. B., & Yonker, L. M. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24981 · Cited by 52
Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
Khan, N., Chen, X., & Geiger, J. D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.595888 · Cited by 51

Authors: Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P.
Affiliations: Agency for Science, Technology and Research (SG)
National University of Singapore (SG)
Corresponding author: Rénia, Laurent
MacAry, Paul A.
Ng, Lisa F. P.
ORCID: Tay, Matthew Zirui
Poh, Chek Meng
Rénia, Laurent
MacAry, Paul A.
Ng, Lisa F. P.
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2020-04-28
Volume: 20
Issue: 6
Pages: 363-374
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/s41577-020-0311-8
PMC: PMC7187672
OpenAlex: W3018517500
Cited by: 4,360
References: 136
Citations by year: 2026: 82 · 2025: 169 · 2024: 320 · 2023: 552 · 2022: 899 · 2021: 1369 · 2020: 961
FWCI: 44.76
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
National University of Singapore (submittedVersion)
Funders: Medical Research Council
Biomedical Research Council
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords: SARS-CoV-2, COVID-19 pandemic, immune response, inflammation, pathophysiology, immune dysregulation, SARS-CoV, MERS-CoV, lower respiratory tract infection, immune regulation, antiviral therapy, therapeutic interventions
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Animals, Humans, Inflammation, Pneumonia, Viral, Coronavirus Infections, Disease Progression, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The trinity of COVID-19: immunity, inflammation and intervention

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks